Officially established in February 2009 at MGH, MIT and Harvard, The Phillip T. and Susan M. Ragon Institute has the dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently to establish itself as a world leader in the collaborative study of immunology.Read more
Harnessing the immune system to prevent and cure human disease
Previously undetected mutation in a subline of C57BL/6 mice could compromise results of many previous studies B...
- May 17, 2016
A sub-Saharan African donor's blood has yielded remarkable finds that could be crucial in the search for an AIDS vaccine. An infected donor's immune s...
- May 16, 2016
Last Month, the Ragon Instiute welcomed Dr. Facundo Batista—an internationally renowned expert in the field...
- April 11, 2016
On March 23, DayZero Diagnostics was announced as the winner of the Harvard Business School (HBS) New Venture Competition. DayZero Diagnostics, hea...
About the Ragon Institute